Current Neuropharmacology aims to provide current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Articles from the journal Current Neuropharmacology , Volume 14 Issue 7:
- Editorial (Thematic Selection: Inflammatory and Immune Responses in Depression)
- Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression
- Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
- Animal Models of Maternal Immune Activation in Depression Research
- A Potential Contribution of Chemokine Network Dysfunction to the Depressive Disorders
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
- Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem
- Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
- Gap Junction Blockers: An Overview of their Effects on Induced Seizures in Animal Models
- Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol
For details on the articles, please visit this link :: http://bit.ly/2csqKVy